Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- LITB +5.3%, JOUT +1.0%
M&A news:
- CSOD +6.7% (has received interest from buyers, according to Bloomberg)
Select metal/miners trading higher:
- MTL +16.7%, BBL +5.1%, BHP +4.4%, MT +2.2%, CLF +1.9%, FCX +1.2%, RIO +1.2%
Select oil/gas related names showing strength:
- PACD +22%, SDRL +17.3%, CRC +12.4%, OAS +9.1%, BTE +9.1%, WLL +8.6%, LPI +8.6%, MRO +7.1%, RIG +7.1%,WFT +7%, ESV +6.7%, SSL +6.5%
- CHK +5.6%, HOS +5%, BBG +4.3%, COP +4%, STO +2.8%, YNDX +2.7%, RDS.A +2.6%, BP +2.4%, SWN +2.4%, SLB+2%, TOT +1.9%, XOM +1.6%, CVX +1.5%
Other news:
- AKAO +53.3% (announces positive results in Phase 3 cUTI and CRE clinical trials of Plazomicin)
- SGY +18% (announces extensions to restructuring support agreement, purchase and sale agreement and credit agreement)
- ATW +9.8% (continued strength in the shipping space)
- NE +7.3% (Noble Corp PLC and certain subsidiaries of Royal Dutch Shell plc (RDS.A) have agreed to amend the existing long-term contracts on three ultra-deepwater drillship)
- PHMD +5.2% (continued strength)
- AXON +1.8% (presented new data analysis showing addition of intepirdine to standard therapy may help people with Alzheimer's Disease maintain independence longer)
Analyst comments:
- REGN +4.6% (upgraded to Neutral at Chardan Capital Markets)
- AMD +1.7% (upgraded to Outperform from Market Perform at BMO Capital)
- ABB +1.3% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- FMC +1.1% (upgraded to Buy from Neutral at Goldman)